Douglas Kerr

Senior Director, Neurology Research & Development at Biogen MA, Inc.

Douglas Kerr

Douglas Kerr

Senior Director, Neurology Research & Development at Biogen MA, Inc.

Biography

Douglas Kerr is on the board of Triplet Therapeutics, Inc. and Chief Medical Officer for Generation Bio Co. In the past Dr. Kerr was Vice President-Neurology at Shire Plc. He received an MBA from Princeton University and a doctorate from Sidney Kimmel Medical College.

Overview
RelSci Relationships

800

Number of Boards

3

Birthday

1967

Age

53

Relationships
RelSci Relationships are individuals Douglas Kerr likely has professional access to. A relationship does not necessarily indicate a personal connection.

President at Cure SMA

Relationship likelihood: Strong

Chief Scientific Officer at Cure SMA

Relationship likelihood: Strong

Scientific Co-Founder at Q Therapeutics, Inc.

Relationship likelihood: Strong

Medical Director at Cure SMA

Relationship likelihood: Strong

Professor at The Ohio State University - College of Medicine

Relationship likelihood: Strong

Member, Scientific Advisory Board at Cure SMA

Relationship likelihood: Strong

Member, Scientific Advisory Board at Cure SMA

Relationship likelihood: Strong

Member, Medical Advisory Council at Cure SMA

Relationship likelihood: Strong

Member, Medical Advisory Council at Cure SMA

Relationship likelihood: Strong

Member, Board of Directors at Cure SMA

Relationship likelihood: Strong

Paths to Douglas Kerr
Potential Connections via
Relationship Science
You
Douglas Kerr
Senior Director, Neurology Research & Development at Biogen MA, Inc.
Education

Princeton University is a vibrant community of scholarship and learning that stands in the nation's service and in the service of all nations. Chartered in 1746, Princeton is the fourth-oldest college in the United States. Princeton is an independent, coeducational, nondenominational institution that provides undergraduate and graduate instruction in the humanities, social sciences, natural sciences and engineering. As a world-renowned research university, Princeton seeks to achieve the highest levels of distinction in the discovery and transmission of knowledge and understanding. At the same time, Princeton is distinctive among research universities in its commitment to undergraduate teaching. Today, more than 1,100 faculty members instruct approximately 5,000 undergraduate students and 2,500 graduate students. The University's generous financial aid program ensures that talented students from all economic backgrounds can afford a Princeton education.

Career History
Chief Medical Officer
2019 - Current

Generation Bio Co. is a genetic medicines company focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.

Senior Director, Neurology Research & Development
Current

Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.

Advisor
Current

Atlas Venture focuses on investments in early-stage companies operating in the fields of biotechnology. The firm partners with entrepreneurs to build companies around innovative science.

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

Douglas Kerr is affiliated with Generation Bio Co., Biogen MA, Inc., Atlas Venture, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Douglas Kerr. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Douglas Kerr's profile does not indicate a business or promotional relationship of any kind between RelSci and Douglas Kerr.